Endocrine Abstracts

Primary aldosteronism (PA) is the most frequent cause of endocrine arterial hypertension. PA is known to cause a higher cardiovascular morbidity, which is reduced by specific therapy of PA. Numerous studies suggest that mineralocorticoid excess may influence mineral homeostasis. On the other side, parathyroid hormone excess has been linked to cardiovascular disease. Increasing evidence supports a bidirectional interaction between aldosterone and PTH which might lead to a higher cardiovascular risk.